Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Youngmin Han

Showing results (161-170 of 190) with videos related to

Pageof 19
Sort By:
Annals of Surgery|September 11, 2024
Diagnostic Performance of Surgical Indication for Branch-duct or Mixed-type Intraductal Papillary Mucinous Neoplasms of the Revised International Association of Pancreatology (IAP) 2023 GuidelinesHye-Sol Jung, Youngmin Han, Yoon Soo Chae, et al.
JAMA Surgery|January 17, 2024
Optimal Surveillance Interval of Branch Duct Intraductal Papillary Mucinous Neoplasm of the PancreasYoungmin Han, Wooil Kwon, Mirang Lee, et al.
Clinical Chemistry|September 30, 2022
Parallel Analysis of Pre- and Postoperative Circulating Tumor DNA and Matched Tumor Tissues in Resectable Pancreatic Ductal Adenocarcinoma: A Prospective Cohort StudyJee-Soo Lee, Youngmin Han, Won-Gun Yun, et al.
Annals of Surgical Treatment and Research|May 25, 2022
Predicting prognosis and evaluating the benefits of adjuvant chemotherapy depending on the tumor location in intrahepatic cholangiocarcinoma: focusing on the involvement of below 2nd bile duct confluenceHee Ju Sohn, Hongbeom Kim, Jae Ri Kim, et al.
Medicine|June 4, 2016
Impact of Type of Surgery on Survival Outcome in Patients With Early Gallbladder Cancer in the Era of Minimally Invasive Surgery: Oncologic Safety of Laparoscopic SurgeryJin-Young Jang, Jin Seok Heo, Youngmin Han, et al.
Journal of Hepato-Biliary-Pancreatic Sciences|October 22, 2019
Proposal of the minimal number of retrieved regional lymph nodes for accurate staging of distal bile duct cancer and clinical validation of the three-tier lymph node staging system (AJCC 8th edition)Jae Seung Kang, Ryota Higuchi, Jin He, et al.
Molecular & Cellular Proteomics : MCP|August 3, 2024
Development of a Fit-For-Purpose Multi-Marker Panel for Early Diagnosis of Pancreatic Ductal AdenocarcinomaHyeonji Kim, Sunghyun Huh, Jungkap Park, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|September 15, 2019
Effects of Pancreatic Enzyme Replacement Therapy on Body Weight and Nutritional Assessments After Pancreatoduodenectomy in a Randomized TrialHongbeom Kim, Yoo-Seok Yoon, Youngmin Han, et al.
Gut and Liver|August 26, 2020
Comparison of Clinical Outcomes of Borderline Resectable Pancreatic Cancer According to the Neoadjuvant Chemo-Regimens: Gemcitabine versus FOLFIRINOXYoo Jin Choi, Yoonhyeong Byun, Jae Seung Kang, et al.
Frontiers in Oncology|August 28, 2020
Gemcitabine-Based Neoadjuvant Treatment in Borderline Resectable Pancreatic Ductal Adenocarcinoma: A Meta-Analysis of Individual Patient DataFrancesco Giovinazzo, Fiammetta Soggiu, Jin-Young Jang, et al.
Pageof 19

Showing results (161-170 of 190) with videos related to

Sort By:
Pageof 19
Annals of Surgery|September 11, 2024
Diagnostic Performance of Surgical Indication for Branch-duct or Mixed-type Intraductal Papillary Mucinous Neoplasms of the Revised International Association of Pancreatology (IAP) 2023 GuidelinesHye-Sol Jung, Youngmin Han, Yoon Soo Chae, et al.
JAMA Surgery|January 17, 2024
Optimal Surveillance Interval of Branch Duct Intraductal Papillary Mucinous Neoplasm of the PancreasYoungmin Han, Wooil Kwon, Mirang Lee, et al.
Clinical Chemistry|September 30, 2022
Parallel Analysis of Pre- and Postoperative Circulating Tumor DNA and Matched Tumor Tissues in Resectable Pancreatic Ductal Adenocarcinoma: A Prospective Cohort StudyJee-Soo Lee, Youngmin Han, Won-Gun Yun, et al.
Annals of Surgical Treatment and Research|May 25, 2022
Predicting prognosis and evaluating the benefits of adjuvant chemotherapy depending on the tumor location in intrahepatic cholangiocarcinoma: focusing on the involvement of below 2nd bile duct confluenceHee Ju Sohn, Hongbeom Kim, Jae Ri Kim, et al.
Medicine|June 4, 2016
Impact of Type of Surgery on Survival Outcome in Patients With Early Gallbladder Cancer in the Era of Minimally Invasive Surgery: Oncologic Safety of Laparoscopic SurgeryJin-Young Jang, Jin Seok Heo, Youngmin Han, et al.
Journal of Hepato-Biliary-Pancreatic Sciences|October 22, 2019
Proposal of the minimal number of retrieved regional lymph nodes for accurate staging of distal bile duct cancer and clinical validation of the three-tier lymph node staging system (AJCC 8th edition)Jae Seung Kang, Ryota Higuchi, Jin He, et al.
Molecular & Cellular Proteomics : MCP|August 3, 2024
Development of a Fit-For-Purpose Multi-Marker Panel for Early Diagnosis of Pancreatic Ductal AdenocarcinomaHyeonji Kim, Sunghyun Huh, Jungkap Park, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|September 15, 2019
Effects of Pancreatic Enzyme Replacement Therapy on Body Weight and Nutritional Assessments After Pancreatoduodenectomy in a Randomized TrialHongbeom Kim, Yoo-Seok Yoon, Youngmin Han, et al.
Gut and Liver|August 26, 2020
Comparison of Clinical Outcomes of Borderline Resectable Pancreatic Cancer According to the Neoadjuvant Chemo-Regimens: Gemcitabine versus FOLFIRINOXYoo Jin Choi, Yoonhyeong Byun, Jae Seung Kang, et al.
Frontiers in Oncology|August 28, 2020
Gemcitabine-Based Neoadjuvant Treatment in Borderline Resectable Pancreatic Ductal Adenocarcinoma: A Meta-Analysis of Individual Patient DataFrancesco Giovinazzo, Fiammetta Soggiu, Jin-Young Jang, et al.
Pageof 19